ArticleJournal of nanobiotechnology2024

Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism.

Yuying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.